Ugwumba Chidozie 13D/13G Filings for Finch Therapeutics Group, Inc. (FNCH)

Ugwumba Chidozie 13D and 13G filings for Finch Therapeutics Group, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-12-13
5:20 pm
Purchase
2023-12-0813GFinch Therapeutics Group, Inc.
FNCH
Ugwumba Chidozie160,366
9.990%
43,699increase
(+37.46%)
Filing
2022-02-14
3:46 pm
Purchase
2021-12-3113GFinch Therapeutics Group, Inc.
FNCH
Ugwumba Chidozie116,667
7.370%
116,667increase
(New Position)
Filing